Fundraising Fox
/Companies
Sign in

Rhizome AI

YC W26

New York City, US · Founded 2025 · Delaware corporation · 1 employees · Hiring · 2 known investors

Find your way into Rhizome AI

Sign up to see every warm intro you have to Rhizome AI

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rhizome AI team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention. The product serves pharmaceutical companies, consultants, and researchers who need to understand regulatory positions and guidance from FDA, EMA, and other regional authorities.

AI & Machine LearningEnterprise SoftwareHealthtechUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (W26)

Rhizome AI was founded in 2025 by Chetan Mishra.

CMChetan Mishra
Chetan MishraFounderChetan Mishra is a software engineer who previously worked at Instabase where he closed enterprise deals, and has experience with vector databases and machine learning research in the life sciences domain.

Investors · 2

Tabula Rasa Venturesreported$50K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

Funding

SEC filings, press & company announcements

$85K disclosed across 1 of 2 rounds · 2025

▶$85KraisedJan 2026 · 2 investors · Computers
Rule 506(c)
Officers, directors & promoters on the filing
  • Chetan MishraExecutive Officer
Offering amount
$85K
Amount sold
$85K
Minimum investment
$85K
First sale
Nov 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Images

Rhizome AI photoRhizome AI photo

Related companies · 2

AssyroAssyro is an AI medical writing software platform that automates the drafting of clinical study reports, protocols, and patient narratives from source data. It serves pharmaceutical and clinical research organizations by reducing the time and manual effort required for medical writing, quality control, and regulatory submissions.
Greenlight GuruGreenlight Guru provides quality management, product development, and clinical evidence software built specifically for medical device companies. Its platform helps medtech teams manage compliance, design controls, risk, and clinical data collection across the product lifecycle.

Companies working in the same space as Rhizome AI.

Legal entities · 1

corporate structure
Rhizome AI, Inc.

In the news

Rhizome AI - Know what the FDA thinksycombinator.com · Jan 2026Rhizome AI Funding | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Rhizome AI do?
Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention. The product serves pharmaceutical companies, consultants, and researchers who need to understand regulatory positions and guidance from FDA, EMA, and other regional authorities.
Who founded Rhizome AI?
Rhizome AI was founded by Chetan Mishra in 2025.
Who are Rhizome AI's investors?
Rhizome AI's investors include Y Combinator, Tabula Rasa Ventures.
How much funding has Rhizome AI raised?
Rhizome AI has disclosed $85K raised across 1 of its 2 known rounds.
Where is Rhizome AI headquartered?
Rhizome AI is headquartered in New York City, US.